70 related articles for article (PubMed ID: 23200666)
1. A novel derivative of riccardin D induces cell death through lysosomal rupture in vitro and inhibits tumor growth in vivo.
Wang Y; Wang L; Hu Z; Ji Y; Lin Z; Yuan H; Ji M; Lou H
Cancer Lett; 2013 Feb; 329(2):207-16. PubMed ID: 23200666
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
3. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way.
Yue B; Zhang YS; Xu HM; Zhao CR; Li YY; Qin YZ; Wang RQ; Sun D; Yuan Y; Lou HX; Qu XJ
Cancer Lett; 2013 Jan; 328(1):104-13. PubMed ID: 22995069
[TBL] [Abstract][Full Text] [Related]
4. Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo.
Hu Z; Zhang D; Hao J; Tian K; Wang W; Lou H; Yuan H
Cancer Chemother Pharmacol; 2014 Feb; 73(2):397-407. PubMed ID: 24322375
[TBL] [Abstract][Full Text] [Related]
5. Riccardin D induces cell death by activation of apoptosis and autophagy in osteosarcoma cells.
Wang Y; Ji Y; Hu Z; Jiang H; Zhu F; Yuan H; Lou H
Toxicol In Vitro; 2013 Sep; 27(6):1928-36. PubMed ID: 23810952
[TBL] [Abstract][Full Text] [Related]
6. Riccardin D-N induces lysosomal membrane permeabilization by inhibiting acid sphingomyelinase and interfering with sphingomyelin metabolism in vivo.
Li L; Niu H; Sun B; Xiao Y; Li W; Yuan H; Lou H
Toxicol Appl Pharmacol; 2016 Nov; 310():175-184. PubMed ID: 27660101
[TBL] [Abstract][Full Text] [Related]
7. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
Tian HL; Yu T; Xu NN; Feng C; Zhou LY; Luo HW; Chang DC; Le XF; Luo KQ
Cancer Lett; 2010 Nov; 297(1):18-30. PubMed ID: 20494511
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.
Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ
Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029
[TBL] [Abstract][Full Text] [Related]
9. The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
Takiguchi S; Nishino Y; Inoue K; Ikeda M; Kataoka Y; Matsusue K; Nishiyama K; Iguchi H
Oncol Rep; 2012 Jul; 28(1):111-6. PubMed ID: 22484715
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
11. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress.
Ostenfeld MS; Fehrenbacher N; Høyer-Hansen M; Thomsen C; Farkas T; Jäättelä M
Cancer Res; 2005 Oct; 65(19):8975-83. PubMed ID: 16204071
[TBL] [Abstract][Full Text] [Related]
12. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
13. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.
Yue B; Zhao CR; Xu HM; Li YY; Cheng YN; Ke HN; Yuan Y; Wang RQ; Shi YQ; Lou HX; Qu XJ
Biochim Biophys Acta; 2013 Jan; 1830(1):2194-203. PubMed ID: 23085067
[TBL] [Abstract][Full Text] [Related]
14. Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo.
Li W; Tian H; Li L; Li S; Yue W; Chen Z; Qi L; Hu W; Zhu Y; Hao B; Gao C; Si L; Gao F
Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):577-83. PubMed ID: 22595511
[TBL] [Abstract][Full Text] [Related]
15. Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb/c nude mice in-vivo.
Hu H; Chen D; Li Y; Zhang X
J Pharm Pharmacol; 2006 Jan; 58(1):83-9. PubMed ID: 16393467
[TBL] [Abstract][Full Text] [Related]
16. Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B-mediated degradation of BRCA1.
Wang Y; Niu H; Hu Z; Zhu M; Wang L; Han L; Qian L; Tian K; Yuan H; Lou H
J Cell Mol Med; 2019 Mar; 23(3):1798-1812. PubMed ID: 30565390
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
19. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
Fang F; Wang AP; Yang SF
Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
